IN VIVO IMMUNOLOGICAL EFFECTS OF ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) THERAPY IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS

被引：0
|
作者：
Chatzileontiadou, S. [1 ]
Rovati, B. [1 ]
Mariucci, S. [1 ]
Loupakis, F. [2 ,3 ]
Bencardino, K. [4 ]
Manzoni, M. [1 ]
Delfanti, S. [1 ]
Valentino, F. [1 ]
Ricci, V [4 ]
Brugnatelli, S. [1 ]
Ronzoni, M. [4 ]
Falcone, A. [2 ,3 ]
Danova, M. [1 ]
机构：
[1] Fdn IRCCS S Matteo, SC Oncol Med, Pavia, Italy
[2] Azienda USL 6 LIVORNO, Milan, Italy
[3] Univ Pisa, Milan, Italy
[4] HSR San Raffaele, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer
    Bouche, Olivier
    Beretta, Giordano Domenico
    Garcia Alfonso, Pilar
    Geissler, Michael
    CANCER TREATMENT REVIEWS, 2010, 36 : S1 - S10
  • [32] Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
    Chan, David Lok Hang
    Segelov, Eva
    Wong, Rachel S. H.
    Smith, Annabel
    Herbertson, Rebecca A.
    Li, Bob T.
    Tebbutt, Niall
    Price, Timothy
    Pavlakis, Nick
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06):
  • [33] DNA methylation status as a biomarker of anti-epidermal growth factor receptor treatment for metastatic colorectal cancer
    Ouchi, Kota
    Takahashi, Shin
    Yamada, Yasuhide
    Tsuji, Shingo
    Tatsuno, Kenji
    Takahashi, Hidekazu
    Takahashi, Naoki
    Takahashi, Masanobu
    Shimodaira, Hideki
    Aburatani, Hiroyuki
    Ishioka, Chikashi
    CANCER SCIENCE, 2015, 106 (12) : 1722 - 1729
  • [34] Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: A meta-analysis
    Song, Qi-Bin
    Wang, Qi
    Hu, Wei-Guo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (14) : 4365 - 4372
  • [35] Study 20050203/PRIME - Effect of Post-Progression Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (mAb) Therapy In Patients With Wild-Type (WT) KRas Metastatic Colorectal Cancer (mCRC)
    Siena, S.
    Douillard, J. Y.
    Cassidy, J.
    Tabernero, J.
    Burkes, R.
    Barugel, M. E.
    Humblet, Y.
    Cunningham, D.
    Yu, H.
    Krishnan, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S435 - S435
  • [36] Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy
    Martinelli, E.
    De Palma, R.
    Orditura, M.
    De Vita, F.
    Ciardiello, F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 158 (01): : 1 - 9
  • [37] AXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC)
    Cardone, C.
    Blauensteiner, B.
    Moreno-Viedma, V.
    Vitiello, P. P.
    Martini, G.
    Ciardiello, D.
    Simeon, V.
    Rachiglio, A. M.
    Rizzi, D.
    Maiello, E.
    Latiano, T.
    Cremolini, C.
    Argiles Martinez, G.
    Elez, E.
    Falcone, A.
    Tabernero, J.
    Normanno, N.
    Sibilia, M.
    Ciardiello, F.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [38] Personalized medicine in metastatic colorectal cancer treated with anti-epidermal growth factor receptor agents: A future opportunity?
    Tejpar, Sabine
    Piessevaux, Hubert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 2 - 10
  • [39] Resistance to anti-epidermal growth factor receptor in metastatic colorectal cancer: What does still need to be addressed?
    Martini, Giulia
    Ciardiello, Davide
    Vitiello, Pietro Paolo
    Napolitano, Stefania
    Cardone, Claudia
    Cuomo, Antonio
    Troiani, Teresa
    Ciardiello, Fortunato
    Martinelli, Erika
    CANCER TREATMENT REVIEWS, 2020, 86
  • [40] Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents
    Andreia Costa
    Sabine Tejpar
    Hans Prenen
    Eric Van Cutsem
    Targeted Oncology, 2011, 6 : 227 - 233
12345